This study in healthy volunteers aims to answer these questions: * Does the test medicine cause any important side effects? * What are the blood levels of the test medicine and how quickly does the body get rid of it? * How much of the test medicine taken by mouth gets into the bloodstream? * How does the body break down and get rid of the test medicine? This study will take place at one site in Nottingham, United Kingdom, and plans to enrol 8 healthy men aged 30-65 years, who will be involved in both parts of the study.
Age range
30 Years – 65 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Absolute bioavailability - Part 1
Timeframe: Plasma sample collection from pre-dose to 110 hrs post-dose
Amount of AZD5004 excreted (Ae) - Part 2
Timeframe: Urine and faecal samples collected from pre-dose until 168 hours post-dose
Amount of AZD5004 excreted expressed as a percentage of the dose administered (Fe) - Part 2
Timeframe: Urine and faecal samples collected from pre-dose until 168 hours post dose
Cumulative amount of AZD5004 excreted (CumAe) - Part 2
Timeframe: Urine and faecal samples collected from pre-dose until 168 hours post dose
Cumulative amount of AZD5004 excreted expressed as a percentage of the dose administered (CumFe) - Part 2
Timeframe: Urine and faecal samples collected from pre-dose until 168 hours post dose